Navigation Links
Covaris and HORIBA Instruments Form Strategic Relationship
Date:2/13/2013

WOBURN, Mass., Feb. 13, 2013 /PRNewswire/ -- Covaris, Inc., the leader in focused acoustic technologies for the life sciences, is pleased to announce the establishment of a marketing alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.  This alliance integrates the Covaris Adaptive Focused Acoustics (AFA) and the HORIBA particle sizing technologies into the world's first fully automated formulation preparation station with integrated Process Analytical Technology (PAT).

Under the arrangement, the Covaris FS-220 GMP system will be integrated with HORIBA's LA-950V2 platform, providing point-of-use particle size characterization.  This PAT system is ideal for formulation preparation from early animal studies through First-In-Human (FIH) testing.  With full 21 CFR Part 11 compliant software, the combined system offers a complete solution in cGLP/cGMP environments.

Carl Beckett , General Manager of Covaris Process Technologies, states that, "We are enthusiastic about this association.  This combined system will accelerate drug development by improving the quality of studies up to and including FIH testing.  Also, it reduces errors when handing off preparations between the Discovery and Development Research centers and the Contract Research Organizations (CRO) by allowing a completely automated and documented method development.  Additionally, as our clients scale to FIH and ultimately clinical processes, they need to ensure the methods in development are phase appropriate and based on scalable technologies."

According to Dr. Mike Pohl , Vice President of HORIBA's Scientific Division, "Our client base ranges from startups to the largest multinational Pharma and Biotech companies.  As a result of our entering into this relationship with Covaris, our clients gain access to the most advanced technology.  It's critical that the analytic and characterization capabilities keep pace with the formulation technology, through the entire discovery/development cycle."  Dr. Pohl notes that many pharmaceutical customers are located along the East Coast.  "The combination of our Edison, NJ headquarters plus the Woburn, MA location of Covaris, Inc.; gives HORIBA a strong one-two punch to support these customers.  The ability to automate the preparation of formulations, and then document the quality up front prior to a study, will now be readily accessible to our customers."

The HORIBA Group of worldwide companies provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements. Proven quality and trustworthy performance have established widespread confidence in the HORIBA Brand.  

Covaris Process Technologies designs, develops, and markets systems based on patented Adaptive Focused Acoustic (AFA) technology.  The AFA process, based on shock wave physics, delivers controlled, precise, and accurate energy to biological and chemical samples.  The process is non-contact, isothermal, and rapid.  Leading pharmaceutical companies worldwide are using Covaris instruments for Formulation development, of nanosuspensions, liposomes, and nanoemulsions.

Information about Covaris Process Technologies is available at http://www.covarisinc.com
Information about HORIBA Scientific is available at http://www.horiba.com/scientific


'/>"/>
SOURCE Covaris, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Grove Instruments Inc. Oversubscribes First Tranche of $3M in New Series B-1 Financing
2. Cen-Med Enterprises, Leading Supplier to the Healthcare Industry, Debuts New Technical Services Division Dedicated to Repair and Maintenance of Analytical Instruments and Lab Storage Equipment
3. European Market for Dental Instruments Surpasses $652 Million, According to New Market Research
4. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) - Global forecast, Market Share, size, growth and industry analysis (2010-2017)
5. Solos Endoscopys Bariatric Instruments Are Now Available
6. Middle East and Africa Surgical Equipment Market Outlook to 2018 -Electrosurgical Devices, Hand Instruments and Surgical Sutures
7. Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
8. United States Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
9. India Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
10. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
11. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017 Mederi Therapeutics today announced the ... 2468 patients who received  Stretta Therapy  to treat ... Systematic Review and Meta-Analysis of Controlled and Prospective ... of Gastroesophageal Reflux Disease ", was published in ... , MD, head of the Esophageal and Swallowing ...
(Date:2/27/2017)... Feb. 27, 2017  International Biophysics Corporation, a global medical ... today announced a 34% revenue growth in 2016 when compared ... unit sales.  This growth was fueled by its AffloVest® sales ... to the expansion of its global sales of surgical product ... CEO, "As we enter our 25 th year in ...
(Date:2/27/2017)... 2017  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ... 37 th Annual Healthcare Conference on Monday, March ... Boston, MA. A live webcast of Infinity,s ... Infinity,s website at www.infi.com , and will be ... About Infinity,Infinity is an innovative biopharmaceutical company dedicated to ...
Breaking Medicine Technology:
(Date:2/27/2017)... Linda, Ca (PRWEB) , ... February 27, 2017 ... ... Life Sciences, provides an overview on laser diffraction analysis as a tool to ... its capabilities, significance and potential to obtain improved results and novel scientific findings. ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast ... in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the ... Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... 25, 2017 , ... The February 13, 2017, assassination of Kim Jong-nam, the ... agents and the deadly use of chemical weapons. Many questions exist about the effect ... doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and ...
Breaking Medicine News(10 mins):